Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Valeant Pharmaceuticals International Inc (NYSE:VRX)

22.05
Delayed Data
As of Dec 13
 +0.18 / +0.82%
Today’s Change
8.31
Today|||52-Week Range
22.81
+51.86%
Year-to-Date
Valeant (VRX) Touches 52-Week High: Is the Stock Officially Back?
Dec 13 / Zacks.com - Paid Partner Content
Valeant (VRX) in Focus: Stock Moves 11.7% Higher
Dec 11 / Zacks.com - Paid Partner Content
No Two Stocks Are the Same: Cramer's 'Mad Money' Recap (Tuesday 12/12/17)
Dec 12 / TheStreet.com - Paid Partner Content
5 Biotech and Pharma Stocks with FDA Catalysts this December
Nov 30 / Zacks.com - Paid Partner Content
Cramer: These CEOs Are Creating Value
Dec 12 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close21.87
Today’s open22.00
Day’s range20.86 - 22.81
Volume48,398,780
Average volume (3 months)14,987,118
Market cap$7.6B
Data as of 4:00pm ET, 12/13/2017

Growth & Valuation

Earnings growth (last year)-716.47%
Earnings growth (this year)-30.79%
Earnings growth (next 5 years)-2.00%
Revenue growth (last year)-7.39%
P/E ratio5.6
Price/Sales0.52
Price/Book2.41

Competitors

 Today’s
change
Today’s
% change
GLPGGalapagos NV+0.07+0.08%
ACADACADIA Pharmaceutica...+0.76+2.60%
TAROTaro Pharmaceutical ...+0.74+0.70%
----
Data as of 4:00pm ET, 12/13/2017

Financials

Next reporting dateMarch 1, 2018
EPS forecast (this quarter)$0.93
Annual revenue (last year)$9.7B
Annual profit (last year)-$2.4B
Net profit margin-24.90%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Joseph C. Papa
Chief Financial Officer &
Executive VP-Finance
Paul S. Herendeen
Corporate headquarters
Laval, Quă©bec

Forecasts